Founder & CEO, Rheacell GmbH & Co. KG
"FGK's professionalism, flexibility, and deep expertise in clinical trials have consistently exceeded our expectations. Their team's ability to adapt quickly while maintaining the highest quality standards has been instrumental in the success of our Phase I/IIa and Phase IIb studies."